共 50 条
- [4] Re: Patient-Reported Outcomes and Inflammatory Biomarkers in Patients With Locally Advanced/Metastatic Urothelial Carcinoma Treated With Durvalumab in Phase 1/2 Dose-Escalation Study 1108 JOURNAL OF UROLOGY, 2021, 205 (05): : 1513 - 1514
- [8] POTENTIAL PREDICTORS FOR THE UNDER-REPORTING BETWEEN PATIENT-REPORTED AND DOCTOR-REPORTED OUTCOMES IN ADVANCED UROTHELIAL CARCINOMA JOURNAL OF UROLOGY, 2018, 199 (04): : E1042 - E1043